MG132
![]() | |
| Names | |
|---|---|
| IUPAC name
Benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate | |
| Other names
N-Benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal Z-Leu-Leu-Leu-al | |
| Identifiers | |
| 133407-82-6 | |
| ChemSpider | 406728 |
| Jmol 3D model | Interactive image |
| PubChem | 462382 |
| |
| |
| Properties | |
| C26H41N3O5 | |
| Molar mass | 475.63 g·mol−1 |
| Appearance | White solid |
| Solubility | 100 mM in EtOH and DMSO |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
MG132 is a specific, potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM). It reduces the degradation of ubiquitin-conjugated proteins in mammalian cells and permeable strains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities. MG132 activates c-Jun N-terminal kinase (JNK1), which initiates apoptosis. MG132 also inhibits NF-κB activation with an IC50 of 3 µM and prevents β-secretase cleavage.
References
This article is issued from Wikipedia - version of the Sunday, April 24, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
